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In Italy, B and C are the predominant serogroups 
among meningococci causing invasive diseases. 
Nevertheless, in the period from 2013 to 2016, an 
increase in serogroup W Neisseria meningitidis (MenW) 
was observed. This study intends to define the main 
characteristics of 63 MenW isolates responsible of 
invasive meningococcal disease (IMD) in Italy from 2000 
to 2016. We performed whole genome sequencing on 
bacterial isolates or single gene sequencing on culture-
negative samples to evaluate molecular heterogeneity. 
Our main finding was the cocirculation of the Hajj and 
the South American sublineages belonging to MenW/
clonal complex (cc)11, which gradually surpassed the 
MenW/cc22 in Italy. All MenW/cc11 isolates were fully 
susceptible to cefotaxime, ceftriaxone, ciprofloxacin, 
penicillin G and rifampicin. We identified the full-
length NadA protein variant 2/3, present in all the 
MenW/cc11. We also identified the fHbp variant 1, 
which we found exclusively in the MenW/cc11/Hajj 
sublineage. Concern about the epidemic potential of 
MenW/cc11 has increased worldwide since the year 
2000. Continued surveillance, supported by genomic 
characterisation, allows high-resolution tracking of 
pathogen dissemination and the detection of epidemic-
associated strains.
Introduction
The history of the global spread of invasive 
meningococcal disease (IMD) caused by serogroup 
W  Neisseria meningitidis  (MenW) started in the year 
2000, following an international emergency during 
the annual Hajj season in Saudi Arabia [1]. Before 
that, MenW had rarely been recorded as the cause 
of outbreaks but rather of sporadic IMD, with a low 
reported incidence [1]. Recently, MenW has been 
spreading in different countries worldwide [2-6]. It 
is of concern that in the United Kingdom (UK), MenW 
IMD incidence has increased year by year, reaching 
24% of all IMD laboratory-confirmed cases in the 
epidemiological year 2014/15 [5,7]. In the Netherlands, 
in the epidemiological year 2015/16, the MenW 
incidence (0.15 cases per 100,000 inhabitants) was 
fivefold higher than the average incidence (0.03 cases 
per 100,000) reported in the period from 2002/03 to 
2014/15 [7].
Whole genome sequencing (WGS) evidenced the 
heterogeneity of meningococci belonging to serogroup 
W/cc11 from different geographical areas and identified 
several genomic types by country [5,8]. As reported by 
Lucidarme et al. [5,9], genomic comparison classified 
most of MenW/cc11 as lineage 11.1. Moreover, this 
lineage includes two sublineages: Hajj and South 
American (previously designated the ‘South American/
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UK strain’) [5,9]. The first sublineage comprises the 
MenW/cc11 Hajj outbreak strain, the sub-Saharan 
African MenW/cc11 strains from epidemic periods and 
the endemic South African MenW/cc11 strain [9]. The 
second sublineage contains three main strains: the 
South American strain, the original UK strain (emerged 
in 2009 in the UK) and the UK 2013 strain [9].
The Hajj sublineage appeared in Saudi Arabia in 2000, 
spreading first in the African meningitis belt and then, 
with smaller outbreaks, in South Africa [4,8,10]. In the 
UK, this sublineage caused IMD in the period from 2000 
to 2004; after that, it was replaced by the endogenous 
MenW/cc11 strain [4,9]. In France, eight MenW/cc11 
cases were reported between January and April 2012 
as linked to recent travel history to Sub-Saharan Africa 
during the MenW epidemic [11,12].
In South America, an increase in the proportion of 
MenW IMD cases has also been reported in early 2000 
[2]. With the exception of one IMD case reported in 
Brazil [3], the South American MenW/cc11 isolates 
were not identified as Hajj strain at that time. Later, the 
so-called South American sublineage was responsible 
for clusters in southern Brazil (2003–05), in the United 
States (US) (2008–09) and in Chile (2010–12) [4]. In 
Europe, and in particular in the UK, Ireland and France, 
clusters of MenW belonging to the South American 
strain sublineage were reported more recently, 2009–
15 [8]. In Sweden, the UK 2013 strain, belonging to 
the South American sublineage, was the cause of an 
increase in MenW IMD starting from 2014 [6].
In Italy, as in the other European countries, serogroups 
B and C are predominant, with an increase in the 
proportion of isolates of serogroup Y from 2% in 
2007 to 17% in 2013 [13]. Even though serogroup W 
has rarely been identified in the country, an increase 
was observed following the global spread of these 
meningococcal strains [7,14].
Here, the genetic variation within and between 
meningococci associated with invasive disease 
was assessed by molecular analysis of  N. 
meningitidis serogroup W collected from 2000 to 2016 
for an overview of the phylogenetic diversity among 
strains circulating in Italy. Moreover, the rapid increase 
in MenW cases and the contemporaneous introduction 
of serogroup B  N. meningitidis  (MenB) vaccine 
(4CMenB) into the national immunisation schedule 
triggered us to study the vaccine antigen genes and 
their genetic variability. Although this vaccine is 
licensed for prevention of MenB disease, the antigens 
are not specific to this capsular group, and a potential 
cross-recognition and protection against other 
meningococcal serogroups deserves to be evaluated.
 
Methods
Surveillance of invasive meningococcal disease
The IMD National Surveillance System (NSS) is based 
on mandatory reporting to the Ministry of Health 
and to the Italian Institute of Public Health (Istituto 
Superiore di Sanità (ISS),  http://www.iss.it/mabi). 
ISS, as national reference laboratory (NRL), acts as 
Figure 1
Neisseria meningitidis serogroup W causing invasive meningococcal disease, by year, Italy, 2000–2016 (n = 63)
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coordinator of the NSS. Within the surveillance system, 
the hospital laboratories collect bacterial isolates and/
or clinical samples from IMD cases and send them to 
the NRL for serogroup identification or confirmation 
and for molecular investigations. The NRL collects 
demographic and relevant clinical data (i.e. vaccination 
history) from all notified IMD cases in a dedicated 
database.
The data are analysed using EpiInfo software (version 
3.5.3, 26 January 2011).
Microbiological analyses
For the samples sent to the NRL, the serogroup was 
identified or confirmed by slide agglutination with 
commercial antisera (Thermo Scientific,  Waltham, 
Massachusetts,  US) or by multiplex PCR [15]. For 
the bacterial isolates, susceptibility to cefotaxime, 
ceftriaxone, ciprofloxacin, penicillin G and rifampicin 
was determined by the minimum inhibitory 
concentration (MIC) test strip method (Liofilchem, 
Roseto degli Abruzzi, Italy) on Mueller-Hinton agar 
(Thermo Scientific, Waltham, Massachusetts, US) 
supplemented with 5% of sheep blood. The breakpoints 
were those recommended by the European Committee 
on Antimicrobial Susceptibility Testing (EUCAST) [16]. 
Chromosomal DNA was extracted using the QiAmp 
mini kit (Qiagen, Hilden, Germany) from an overnight 
culture or directly from the clinical sample, blood 
or cerebrospinal fluid (CSF). Multilocus sequence 
typing (MLST), PorA and FetA typing, MenB vaccine 
antigen variants and  penA  gene were identified using 
the PubMLST.org database (http://pubmlst.org/
neisseria/). The genotypic formula comprised capsular 
group:  porA  (P1).VR1,VR2:  fetA  VR: ST(cc). The MenW/
cc11 isolates were characterised for the allelic profile 
of six antigen-encoding genes (porA, porB, fetA, nadA, 
nhba and fHbp) suggested by Mustapha et al. as typical 
of the main MenW/cc11 sublineages [4].
Whole genome sequencing
Cultivated isolates were analysed by WGS. For each 
isolate, 1 ng of DNA was used to prepare the sequencing 
libraries following the Nextera XT DNA protocol. The 
Illumina MiSeq platform (kit v3, 600 cycles) was used 
for the WGS analysis. A first quality check of the raw 
sequence data was performed using FastQC [17]. 
Reads were trimmed using the software Sickle [18] to 
maintain a Q score > 25, and de novo assembly was 
carried out with the ABySS software version 1.5.2 (k 
parameter = 63) [19]. Contigs longer than 500 bp were 
selected using an ad hoc script and kept for further 
analysis. The final assembly ranged from 84 to 316 
(median: 209) contigs per sample (N50: 10,999–59,092 
bp; median: 19,790 bp), covering the ca 2.2 Mb of 
the N. meningitidis genome.
Genome comparison
Genomes were uploaded to the PubMLST.org database 
(http://pubmlst.org/neisseria/) and compared using 
the BIGSdb Genome Comparator [20] through gene-
by-gene analysis. Phylogenetic analysis of the isolates 
was performed by core genome MLST (cgMLST) [21]. 
Incomplete loci were automatically removed from 
the distance matrix calculation for the neighbour-net 
graphs. The resulting distance matrices were visualised 
Figure 2
Number of invasive meningococcal disease cases caused by Neisseria meningitidis, by clonal complex, Italy, 2000–2016 
(n = 51)
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as neighbour-net networks, generated by SplitsTree4 
(version 4.13.1) [22].
Statistics
Change in the average annual incidence of MenW from 
2000 to 2012 vs 2013 to 2016 was evaluated using a 
negative binomial regression model.
Results
From 2000 to 2016, 3,540 laboratory-confirmed IMD 
cases were reported within the NSS for IMD in Italy, 
with an incidence of 0.37 per 100,000 in 2016 (www.
iss.it/mabi/, last access: 3 September 2018).
For 2,357 IMD cases, the capsular serogroup was 
identified: 1,249 were B, 861 were C, 161 were Y, 63 were 
W, 17 were A, five were X and one was 29E. One isolate 
was capsule null locus (cnl). The majority of cases were 
due to serogroups B and C, with proportions of 36% 
and 42%, respectively, in 2016.
As shown in Figure 1, MenW was rare from 2000 until 
2012, with an average annual incidence of 0.004 per 
100,000 population (30 cases). From 2013 to 2016, the 
average annual incidence grew to 0.01 per 100,000 
population (33 cases), significantly higher than in the 
previous time period (p < 0.05). In 2016, 13 MenW cases 
were identified, with an incidence of 0.02 per 100,000 
population, four times higher than the average value of 
0.005 per 100,000 population observed in the previous 
years 2000 to 2015.
Among the 63 MenW IMD cases, 53 samples were sent 
to the NRL for further analyses: 47 bacterial isolates 
and six CSF or blood samples.
Demographic and clinical data of Neisseria 
meningitidis serogroup W cases
The median age of the 63 MenW cases was 20 years 
(mean: 29 years), ranging from 1 month to 86 years. 
Until 2005, MenW was responsible of IMD cases 
exclusively among children younger than 10 years (the 
median age was 1 year), except for one. In the period 
from 2006 to 2016, the median age increased to 26 
years.
The female:male ratio was 28:35. Meningitis (25 
cases) and septicaemia (22 cases) were the main 
clinical presentations, followed by meningitis plus 
septicaemia (16 cases). Four cases had an atypical 
clinical presentation: two (aged 3 and 26 years) had 
arthritis; one (20 years-old) had a pericolic abscess 
and one (5 months-old) had dysentery. Six patients 
(aged between 22 and 63 years) died, defining a case 
fatality rate of 10%.
Eleven patients came from foreign countries: Eritrea 
(n = 1) [23], Mali (n = 1) [23], Ivory Coast (n = 1), 
Morocco (n = 1) [23], Niger (n = 1), Nigeria (n = 5) and 
Somalia (n = 1).
Table
Molecular characterisation of Neisseria meningitidis MenW/cc11 bacterial isolates, Italy 2000–2016 (n = 18)
Bacterial 
isolate ID ID (http://pubmlst.org/Neisseria) Year of isolation BAST cgMLST sublineage
Six antigen-encoding 
gene profile
1142 42867 2001 898 Hajj a
1505 42851 2004 898 Hajj a
1638 42852 2005 898 Hajj a
2205 42884 2009 898 Hajj a
2517 42886 2013 898 Hajj a
2693 36847 2014 898 Hajj a
2767 42888 2015 898 Hajj a
2808 44961 2016 898 Hajj a
2857 51615 2016 898 Hajj a
2904 51617 2016 898 Hajj a
2916 51618 2016 898 Hajj a
2940 56641 2016 898 Hajj a
2509 42885 2013 2 South American b
2593 36848 2014 2 South American b
2585 36849 2014 2 South American b
2685 36845 2015 2 South American b
2858 51616 2016 2 South American b
2602 42887 2013 6 Singleton c
BAST: Bexsero antigen sequence typing; cgMLST: core genome multilocus sequence typing; ID: identification code.
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Microbiological and molecular analyses
Antimicrobial susceptibility
Of the 47 MenW bacterial isolates received at the 
NRL, 44 could be cultured and tested for antimicrobial 
susceptibility. All of them were susceptible to 
cefotaxime, ceftriaxone, ciprofloxacin and rifampicin. 
Moreover, 14 showed decreased susceptibility to 
penicillin G (PenI, 0.064 > MIC ≥ 0.25) with a MIC50 and 
MIC90 of 0.064 mg/L and 0.19 mg/L, respectively.
MLST and genotypic formula
The molecular characterisation was performed at the 
NRL for 51 of 53 MenW. Two samples were not suitable 
for the molecular analyses. MLST identified two main 
clonal complexes, cc22 (n = 25) and cc11 (n = 23). In 
addition, two isolates were cc23 and one was cc60.
As shown in  Figure 2, the main clonal complex 
between 2000 and 2012 was cc22 (19/26); from 2013 
onward, the cc11 (19/25) was predominant. Among 
the 25 cc22 bacterial isolates, eight sequence types 
(STs) were identified: ST-22, ST-184, ST-3189, ST-904, 
ST-1286, ST-1959, ST-6779 and ST-11935. Among 
them, 12 genotypic formulas were reported, of which 
W:P1.18–1,3:F4–1:ST-22(cc22) was the most frequent 
(five bacterial isolates; Supplementary Table S1). 
The 23 MenW/cc11 (18 bacterial isolates and five 
clinical samples) belonged to ST-11 and presented a 
single genotypic formula, W:P1.5,2:F1–1:ST-11(cc11) 
(Supplementary Table S1). The cc23 isolates belonged 
to ST-23 and ST-9253 and the cc60 isolate to ST-913. 
Whole genome sequencing
Whole genome sequencing was performed to identify: 
the Bexsero antigen sequence types (BAST), the 
cgMLST, the six antigen-encoding gene profile and 
the penA gene alleles.
BAST typing
As shown in the  Table, MenW/cc11 clustered in three 
BAST: BAST 898 (characterised by fHbp peptide variant 
1.9, NHBA peptide 96, NadA peptide 6, PorA VR1 5 and 
PorA VR2 2) for 12 bacterial isolates; BAST 2 (fHbp 
2.22, NHBA 29, NadA 6, PorA VR1 5 and PorA VR2 2) for 
five; BAST 6 (fHbp 2.151, NHBA 29, NadA 6, PorA VR1 5 
and PorA VR2 2) for the remaining one.
4CMenB variant antigens among MenW/cc22
The 4CMenB variant antigens identified among MenW/
cc22 isolates were: fHbp peptide variant 2.16, NHBA 
peptide 20, NadA interrupted by an IS element. The 
PorA VR1,VR2 were 18–1,3 in eight isolates, 5–1,10–1 in 
three isolates and 5,2 in one isolate.
cgMLST
We included 1,467 of the 1,605 core genome loci in 
the cgMLST analysis (138 loci incompletely assembled 
were excluded) for 18 MenW/cc11 and seven reference 
genomes.
As shown in Figure 3, the 18 MenW/cc11 split into two 
main sublineages corresponding to those described 
by Lucidarme et al. [5]. Twelve genomes (ID 36847, 
42851, 42852, 42867, 42884, 42886, 42888, 44961, 
51615, 51617, 51618 and 56641) grouped together with 
reference genomes belonging to the Hajj sublineage, 
with a mean distance of 89 loci with allelic differences. 
Eight of these 12 genomes (ID 36847, 42886, 42888, 
44961, 51615, 51617, 51618 and 56641) clustered in a 
subgroup; they had been isolated between 2013 and 
2016 and five of them were associated with MenW IMD 
in patients with Nigerian nationality (Supplementary 
Table S2).
Our 12 MenW/Hajj sublineage genomes were compared 
with 128 MenW genomes with the genotypic formula 
W:P1.5,2:F1–1:ST-11(cc11) and fHbp variant 1.9, 
identified from IMD cases in Africa (www.neisseria.
org; last accessed: 24 November 2017). All genomes 
showed a mean distance of 60 loci (data not shown).
Five MenW/cc11 genomes (ID 36845, 36848, 36849, 
42885 and 51616) clustered together with two genomes 
in the South American sublineage (ID 30154, as the 
original UK strain reference, and ID 30167, as the UK 
2013 strain reference) [9] with a mean distance of 74 
loci. In particular, genomes ID 51616 and ID 30167 
showed a higher proximity. The analysis of 27 of 30 
genes distinguishing the original and the novel UK 
strains [9] confirmed that ID 51616 was a UK 2013-strain. 
The remaining four genomes showed a higher similarity 
to the original UK strain. The ID 42887 genome was 
close to the reference ID 21587 (South Africa 2003) in a 
branch far from both the main sublineages.
For the 12 MenW/cc22 genomes, 1,540 of the 1,605 core 
genome loci were included in the cgMLST analysis, while 
the remaining 65 loci were incompletely assembled. 
The genome comparison highlighted a mean distance 
of 199 loci (Supplementary Figure S1). The cgMLST 
analysis of MenW/cc22 and cc11 highlighted high 
genetic diversity with a mean distance of 588 loci (data 
not shown).
Overall, the majority of MenW/cc11 were Hajj sublineage 
(16/22); in particular, it caused five sporadic IMD cases 
from 2001 to 2013 and 11 cases from 2014 to 2016 
(Supplementary Figure S2). Ten MenW/cc11 Hajj were 
obtained from African refugees and characterised by 
the presence of fHbp allele 9 (Supplementary Table 
S2). The South American sublineage appeared in Italy 
in 2013 and was responsible for five of 22 IMD cases 
(Supplementary Figure S2). One MenW/cc11 (ID 42887), 
identified in 2013, did not belong to any sublineage.
Six antigen-encoding gene profiles among MenW/cc11
Among the 18 MenW/cc11 bacterial isolates, we found 
three known profiles [4], comprising the alleles of porA
, porB, fetA, nadA, nhba and fHbp genes (Table). Profile 
a was found in 12 bacterial isolates: 1, 1, 13, 5 (peptide 
6), 72 (peptide 96), 9; profile b in five isolates: 1, 244, 
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Figure 3
Neighbour-net phylogenetic network based on a comparison of 1,467 core genome loci (cgMLST) of Neisseria meningitidis 
MenW/cc11 genomes Italy 2000–2016 (n = 25)
●  Burkinia Faso/North African isolate, 2001, ID30087 
ID42852, 2005 
ID42851, 2004 ID42867, 2001 
ID42884, 2009 
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The figure includes genomes of 18 isolates from this study and seven reference genomes (black dots) available in the Neisseria PubMLST 
website. Last accessed: 10 April 2017. The Hajj sublineage and the South American sublineage are highlighted with circles. For each genome, 
the ID code from http://pubmlst.org/Neisseria is reported. The scale bar indicates the number of differences between the compared loci.
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13, 5 (peptide 6), 17 (peptide 29), 22; profile c in one 
isolate: 1, 311, 13, 5 (peptide 6), 17 (peptide 29), 160 
(peptide 151).
For four of five clinical samples, we identified nhba 72 
and  fHbp  9 (Supplemetary Table 2). The remaining 
sample was not suitable for the analysis.
As shown in the  Table, the isolates clustered as Hajj 
sublineage showed the profile a, the isolates belonging 
to the South America sublineage showed the profile b 
and the singleton showed the profile c.
penA gene characterisation
The 18 MenW/cc11 bacterial isolates were susceptible 
to penicillin G and showed the  penA  allele 1. Thirteen 
of 24 of MenW/cc22 were PenI, of which 12 harboured 
the penA allele 14 and the remaining one the penA 685.
Discussion
The epidemiology of IMD is constantly changing. The 
national vaccination programmes should consider 
these changes over time and the age groups that are 
affected most.
Since 2000, there has been an increase in the number 
of MenW cases in Europe, America and Africa [2-4]. 
This international context prompted us to ascertain the 
current situation of MenW in Italy and how it had evolved 
over the past 17 years. Although Italy is classified as 
a country with a low incidence of IMD in the overall 
population, the number of MenW notified cases has 
been increasing since 2013. Data collected within the 
established NSS for IMD reported an increase in MenW 
cases, even though the absolute number was lower 
than that reported in other European countries [4-7]. 
In the past, sporadic MenW IMD cases occurred mainly 
among children, but have gradually increased also in 
older age groups, in England since the epidemiological 
year 2013/14, and in the Netherlands since 2015/16 [7].
In 2016, MenW represented 7% of the total IMD 
cases reported in Italy. In contrast to other countries 
[24], very few cases were characterised by atypical 
clinical presentation; it is likely that this is due to the 
small total number of reported cases and incomplete 
available information. In 17 years, cc11 has become the 
prevalent clonal complex among MenW in the country. 
In contrast to what was reported in Australia in 2016 
[25], MenW/cc11 was not associated with the emerging 
resistance to penicillin.
The most interesting finding of this study is that both 
of the MenW/cc11 sublineages, South American and 
Hajj, cocirculate in Italy. Cocirculation has already been 
reported in some parts of the African meningitis belt 
and in South Africa [8], but not in Europe. In the UK in 
the mid-2000s, the Hajj sublineage was replaced by the 
South American sublineage [9]. Likewise, in France, the 
Hajj sublineage, detected up to 2012 [12], was replaced 
in 2013 by the South American sublineage [26]. The 
Hajj sublineage appeared in Italy in 2001 and became 
predominant in 2014. Across the entire study period, 
the Hajj sublineage represented 73% of the MenW/cc11 
identified in Italy.
Five of the 22 MenW/cc11 were South American 
sublineage. They appeared in Italy for the first time in 
2013, causing five IMD among Italian patients. Four of 
them were the original UK strain and only one, in 2016, 
was the UK 2013 strain. As extensively described, 
the UK 2013 strain has been spreading in northern 
European countries since 2013 [6,7,9].
In Italy, the National Immunisation Plan 2017–2019 
recommends the quadrivalent meningococcal vaccine 
for adolescents, as the main group of people affected 
by serogroups Y and W, acting as catch-up or booster of 
the primary immunisation [27]. The immunisation is also 
recommended for travellers to countries endemic for 
the serogroups contained in the vaccine and for people 
at high risk of IMD [27]. Moreover, the recommendation 
for the meningococcal B vaccine (4CMenB) for infants 
before the age of 13 months is administered free of 
charge. Possible cross-protection against other non-B 
meningococci, through the presence of the same 
subcapsular vaccine antigens, need to be evaluated 
[28,29]. In the UK, serum bactericidal antibody (SBA) 
activity, promoted by immunisation with 4CMenB 
vaccine against  N. meningitidis  W strains, was clearly 
demonstrated [28]. Here, all MenW/cc11 meningococci 
showed the NadA peptide 6, belonging to the variant 
2/3, predicted to be cross-protective with the 4CMenB 
NadA variant [28]. Moreover, the MenW/cc11/Hajj 
sublineage isolates showed the fHbp variant 1, one of 
the antigens of the 4CMenB vaccine. The multi-antigen 
typing system [30] together with SBA test [31] could 
define precisely the vaccine coverage against MenW; 
further evaluations are needed to precisely answer this 
question also for the MenW identified in Italy.
Conclusion
In Italy, we observed cocirculation of two sublineages, 
the Hajj and the South American. This is uncommon 
and not reported in other European countries. It is 
likely that the geographical location of our country may 
favour a peculiar epidemiological situation that needs 
to be carefully monitored and evaluated.
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